Draft Letter of Offer filed with BSE for Parmax Pharma public shareholders
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
FedEx Securities, acting as Manager to the Offer, has submitted a Draft Letter of Offer to BSE for the public shareholders of Parmax Pharma Ltd, referred to as the Target Company. This filing signals the start of a formal open offer process, in which public shareholders will be given a chance to tender their shares at a price outlined in the offer document. The acquirer's identity, offer price, and total offer size are expected to be detailed in the final Letter of Offer once it is dispatched.
An open offer is now in process for Parmax Pharma. Shareholders will be able to sell their shares at the offer price once the final document is issued.